Legislation - SB0537

Title: Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
Sponsored by: Senator Hershey
Status: In the Senate - Hearing 2/16 at 1:00 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Requiring a pharmacist, or the pharmacist's designee who is under certain supervision, to inform a certain consumer of the availability of a therapeutically equivalent brand name drug that is the lowest cost alternative to the originally prescribed drug or device and the cost difference between the therapeutically equivalent drug or device and the prescribed drug; altering the cost difference of which a pharmacist is required to inform a retail consumer; requiring a certain determination to be made based on a certain drug benefit; etc.

Committees

Original:: Education, Health, and Environmental Affairs Click to view Recorded Media

Details

Cross-filed with: HB0429

Bill File Type: Regular

Effective Date(s): October 1, 2021

History

Legislation History
Chamber Senate Calendar Date 1/26/2021 Legislative Date 1/26/2021 Action First Reading Education, Health, and Environmental Affairs Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product Proceedings
Chamber Senate Calendar Date 2/02/2021 Legislative Date 2/02/2021 Action Hearing 2/16 at 1:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
Senate	1/26/2021	1/26/2021	First Reading Education, Health, and Environmental Affairs
			Text - First - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
Senate	2/02/2021	2/02/2021	Hearing 2/16 at 1:00 p.m.

File Code

Subjects

Statutes